The FDA announced yesterday that it had reversed a 2003 decision to put a stringent warning on hormone therapy products for ...

Data highlight continued progress in Jazz's brain tumor research and demonstrate the company's commitment to advancing treatment options for patients with ...

Jazz Pharmaceuticals plc  today announced that the company will present five abstracts at the 2025 Society for Neuro-Oncology (SNO) Annual Meeting taking place November 19-23 in Honolulu, Hawaii. The ...